A multicenter study of apheresis collection of peripheral blood mononuclear cells (PBMC) in patients with CD19 expressing malignancies who could be eligible for a CTL019 clinical research trial

Gender
Any

Age Group
Any

At a Glance

IRB#IRB14-0883

Lead PhysicianMichael R. Bishop

Collaborator(s)N/A

EligibilityRecruiting